Page 803 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat

INDEX INDEX 759

Ceftazidime Central tendon (diaphragm), 663 Cestodes, 160 Childbirth
mechanism and use, 189 Central vertigo, 534 Cetirizine, 686 brachial plexus injury in, 448
Pseudomonas aeruginosa, 143 Centriacinar emphysema, 674 Cetuximab, 442 Budd-Chiari syndrome and, 392
Ceftriaxone Cephalexin CFTR gene Graves disease and, 342
Chlamydia spp, 148 mechanism and use, 189 chronic pancreatitis and, 397 low birth weight, 635
for gonococci, 142 Cephalosporins cGMP (cyclic guanosine misoprostol induction, 399
for Haemophilus influenzae, 142 disulfiram-like reaction, 251 monophosphate) neonatal flora, 178
mechanism and use, 189 mechanism and use, 189 atrial natriuretic peptide and, 296 oxytocin and uterine contractions,
meningitis, 180 pseudomembranous colitis, 249 endocrine hormone messenger, 328, 636
meningococci, 142 Pseudomonas aeruginosa, 143 337 postpartum mood disturbances,
typhoid fever, 144 Ceramide trihexoside male sexual response, 627 562
Cefuroxime in sphingolipidoses, 88 Chagas disease, 158 preterm, as common cause of
mechanism and use, 189 Cerebellar degeneration achalasia in, 376 death, 272
Celecoxib, 252, 486 paraneoplastic, 228 Chalk-stick fractures, 463 progesterone levels after, 630
Celiac artery Cerebellar lesions Chancroids, 184 Sheehan syndrome after, 339
mesenteric ischemia, 386 hemisphere, 511 Changes in the elderly, 270 stress incontinence and, 599
structures supplied, 364 lateral, 499 Chaperone protein, 45 Childhood disorders, 557
Celiac disease, 381 medial, 499 Charcoal yeast extract culture Childhood musculoskeletal
autoantibody, 115 tonsillar herniation, 492, 529 Legionella pneumophila, 126, 143 conditions, 461
HLA genes and, 100 vermis lesions, 511 Charcot-Bouchard microaneurysm, Childhood primary brain tumors, 528
IgA deficiency, 116 Cerebellum 516 Child neglect, 556
Celiac sprue, 381 development of, 490 Charcot joints Children
Celiac trunk, 364 input/output of, 499 syphilis, 147 causes of death, 272
Cell biology of bone, 459 tonsils, 492 tabes dorsalis and, 530 Chi-square tests, 264
Cell cycle phases, 46 Cerebral aqueduct of Sylvius, 504 Charcot-Leyden crystals, 674 Chlamydia spp, 148, 184
Cell envelope (bacterial), 124 Cerebral artery distributions, 502 Charcot-Marie-Tooth disease, 524 atypical infections, 179
Cell injury, 207 Cerebral cortex Charcot triad, 397 diagnostic tests for, 148
Cell lysis, 590 aphasia, 514 Charging, tRNA, 44 Giemsa stain, 125
Cell membrane in apoptosis, 208 arterial distribution, 502 Chédiak-Higashi syndrome, 117 Gram stain, 125
Cell surface proteins dominant parietal lesions, 511 Cheilosis, 67 intracellular organism, 127
association and functions, 110 functional areas of, 501 Chelation macrolides, 193
leukocyte adhesion deficiency, 117 hemineglect, 514 hemochromatosis, 395 pneumonia, 683
T cells and, 101 nondominant parietal lesions, 511 lead poisoning, 419 reactive arthritis, 469
Cell trafficking, 47 visual field defects, 514 Chemokines, 108 sulfonamides for, 194
Cell types Cerebral edema delayed hypersensitivity, 112 tetracyclines, 192
labile, 46 diabetic ketoacidosis and, 347 Chemoreceptors, 296 Chlamydia trachomatis
permanent, 46 therapeutic hyperventilation, 501 Chemoreceptor trigger zone (CTZ), eosinophilia, 149
stable (quiescent), 46 Cerebral hemispheres, 490 496 pelvic inflammatory disease, 149
Cellular biochemistry, 46–52 Cerebral palsy, 551 Chemotherapy pneumonia, 179
Cellular injury Cerebral perfusion pressure (CPP), AML and, 432 serotypes, 149
cellular adaptations, 206 501 MDR1 and responsiveness to, UTIs, 600
irreversible, 207 “Cerebriform” nuclei, 430 227 Chlamydophila pneumoniae, 148
reversible, 207 Cerebrospinal fluid (CSF) neutropenia with, 424 pneumonia, 179
Cellulitis, 136, 479 albuminocytologic dissociation, ondansetron, 400 Chlamydophila psittaci
Pasteurella multocida, 149 524 paclitaxel, 48 atypical pneumonia, 148
Cell walls (bacterial), 124 blood-brain barrier and, 496 pancreatic cancer, 398 transmission, 149
Central clearing circulation of, 496, 503 readmissions with, 272 Chloasma (melasma), 476
nuclei, 343 findings in meningitis, 180 treatments for vomiting, 401 Chloramphenicol
rash, 152 Guillain-Barré syndrome, 524 vincristine/vinblastine, 48 aplastic anemia and, 250
Central diabetes insipidus, 338 hydrocephalus, 522 Chemotoxicities, 444 gray baby syndrome, 250
Central/downward transtentorial multiple sclerosis, 523 Cherry hemangiomas, 478 mechanism and use, 192
herniation, 529 neurodegenerative disorders, 521 “Cherry red” epiglottis, 142 pregnancy contraindications, 204
Central nervous system (CNS) origins, 490 Cherry-red spot (macula), 538 protein synthesis inhibition, 191
anesthetic principles for, 549 poliomyelitis, 531 lysosomal storage disease, 88 Chlordiazepoxide, 546
antiarrhythmic adverse effects, production, 493 Chest pain alcohol withdrawal, 572
322, 323 ventricular system, 504 panic disorder, 563 Chlorhexidine, 204
cancer epidemiology, 222 Cerebrovascular disease pneumothorax, 682 Chloride channels
cell types in, 493–494 diabetes mellitus, 346 Chest wall cystic fibrosis, 60
depression, 546 Certolizumab, 487 elastic properties, 665 Chlorine, 204
drug name conventions, 253 Ceruloplasmin Chest X-rays Chloroprocaine, 550
nitrosoureas effect on, 441 free radical elimination by, 210 aortic dissections on, 303 Chloroquine, 200
origins of, 490 Cervical cancer, 645 balloon heart on, 308 malaria, 157
posterior fossa malformations, 491, carcinogens causing, 225 eggshell calcification, 677 Chlorpheniramine, 686
492 epidemiology of, 643 notched ribs on, 299 Chlorpromazine, 573
regional specification of, 506 HIV-positive adults, 177 Wegener granulomatosis on, 315 Chlorthalidone, 609
shock from injury, 310 hydronephrosis with, 599 widened mediastinum on, 137 Chocolate agar
Central nervous system stimulants, oncogenic microbes and, 226 Cheyne-Stokes respirations, 679 Haemophilus influenzae, 126, 142
572 papillomaviruses, 164 Chiari malformations, 492 Cholangiocarcinomas
Central pontine myelinolysis, 524 Cervical rib, 448 Chickenpox Clonorchis sinensis, 160, 161
Central post-stroke pain syndrome, Cervicitis rash, 183 hyperbilirubinemia, 393
515 sexually transmitted infections, 184 VZV, 165 oncogenic microbes and, 226
Central precocious puberty, 637 Cervix Chief cells (parathyroid), 332 sclerosing cholangitis, 395
Central retinal artery occlusion, 538 anatomy of, 625 Chief cells (stomach), 372 Cholangitis, 368, 382, 393, 397
Central sleep apnea, 679 epithelial histology, 626 Child abuse, 556 Cholecalciferol, 70
Central sulcus, 501 lymphatic drainage of, 624 osteogenesis imperfecta and, 51 Cholecystectomy, 396, 397
Central tendency measures, 262 pathology of, 645 reporting requirements, 269 Cholecystitis, 396

FAS1_2019_21_Index_749-806.indd 759 11/21/19 12:27 PM